NCT01827917

The Protection Effect of Speeda® Rabies Vaccine for Human Use

Phase 4 Study of Speeda® Rabies Vaccinia That Use for Protection the Crowd Bitten by Animals to Three-level

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 37 (actual)
• Sponsor: Beijing Center for Disease Control and Prevention · Other Government
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

The objective of this study was to achieve the post-marketing protective effect research of Speeda® rabies vaccine for human use from Chengda Bio.

Detailed description

When found the injury who is bitten by the animal to three-level, the investigators would enroll the participant after explaining the protection and making him signed the informed consent. The patient would inject rabies vaccine as follow the national regulation, meanwhile the investigators would get the blood samples to detect whether the man-killer carries the rabies virus.

Conditions

• Rabies Vaccine Allergy

Interventions

Type	Name	Description
BIOLOGICAL	rabies vaccine	Injection on day 0、7、21

Timeline

• Start date: 2013-02-01
• Primary completion: 2013-12-01
• Completion: 2014-12-01
• First posted: 2013-04-10
• Last updated: 2016-01-20

Locations

1 site across 1 country: China